1-11 of 11
Olga Vinogradova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Siremadlin, a Human Double Minute-2 (HDM2) Inhibitor, Added to Ruxolitinib after Suboptimal Response to Ruxolitinib Alone in Patients with Myelofibrosis: Results from Part 1 of the Phase 1/2 Adore Study

Florian H Heidel, Andrew Charles Perkins, Andreas Reiter, Carl C. Crodel, Caroline Hasselbalch Riley, María Teresa Gómez-Casares, Istvan Takacs, Heiko Becker, Thomas Lehmann, Olga Vinogradova, Kate Burbury, Alessandro M. Vannucchi, Vikas Gupta, Claire Harrison, Marielle Wondergem, Jean-Jacques Kiladjian, Grace Cleary, Angela Zhang, Bruyère Mahuzier, Jagannath Kota, Anirudh Prahallad, David M Ross
Journal: Blood
Blood (2022) 140 (Supplement 1): 590–593.
https://doi.org/10.1182/blood-2022-158501
Published: 2022
Journal Articles

The 15 Year Long-Term Survival of Patients with Chronic Myeloid Leukaemia from 35 Regions of Russian Federation: A Follow up of a Multicenter Observation Study Eutos Osp Initiated By European Leukemia NET

Olga V. Lazareva, Ekaterina Yu. Chelysheva, Olga Vinogradova, Anton Kulikovsky, Varvara I. Bakhtina, Eva Burnasheva, Tatiana Chagorova, Dolgorzhap Dasheeva, Elena Fedorova, Lubov Gavrilova, Nataliya Glonina, Anatoly Golenkov, Tatiana Klitochenko, Tatiana S. Konstantinova, Marina Kosinova, Marina Kozmina, Alexandr Korobkin, Galina Kuchma, Elza Lomaia, Alexander S. Luchinin, Anna Lyamkina, Ludmila Napso, Andrew Proidakov, Gysual Safuanova, Olga Senderova, Vasilisa Skatova, Anton Shutilev, Svetlana Volkova, Sergey Voloshin, Elena Volodicheva, Vera Yablokova, Andrew Zhuravkov, Andrey Zaritsky, Sergei M. Kulikov, Anna G. Turkina
Journal: Blood
Blood (2021) 138 (Supplement 1): 5035.
https://doi.org/10.1182/blood-2021-151371
Published: 2021
Journal Articles

PF-114 in Patients Failing Prior Tyrosine Kinase-Inhibitor Therapy Including BCR::ABL1 T315I

Anna G. Turkina, Olga Vinogradova, Elza Lomaia, Evgeniya Shatokhina, Oleg A. Shukhov, Andrey Zaritskey, Ekaterina Yu. Chelysheva, Dzhariyat Shikhbabaeva, Irina Nemchenko, Anna Petrova, Anastasiya Bykova, Vasily Shuvaev, Nadia Siordia, Jorge E. Cortes, Robert Peter Gale, Michele Baccarani, Oliver Ottmann, Ilya Mikhailov, Fedor Novikov, Veronika Shulgina, Ghermes Chilov
Journal: Blood
Blood (2021) 138 (Supplement 1): 1482.
https://doi.org/10.1182/blood-2021-150120
Published: 2021
Journal Articles

Quality of Life (QoL) and Clinical Outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Ixazomib-Lenalidomide-Dexamethasone (IRd) in a Real-World Setting

Tatyana Ionova, Elena Ado, Lyudmila Anchukova, Elena Babich, Dolgorzhap Dasheeva, Marina Demchenkova, Sergei Dubov, Tatiana Esenina, Lyudmila Ivanova, Kamil Kaplanov, Anna Kopylova, Yulia Kochkareva, Tatiana Kravchuk, Alexander Levanov, Olga Li, Tatiana Mitina, Tatiana Nikitina, Natalia Porfirieva, Elena Rimashevskaya, Oleg Rukavitsyn, Natalia Saraeva, Marina Savinova, Tatiana Shelekhova, Polina Simashova, Mariya Shirokova, Olga Vinogradova, Svetlana Volkova, Anna Zinkovskaya
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134415
Published: 2020
Journal Articles

On a Long Way to the Treatment Free Remisson: The Results of the Long-Term Observation of the Chronic Myeloid Leukemia Patients in Russian Part of EUTOS Population-Based Study

Olga V. Lazareva, PhD, Ekaterina Yu. Chelysheva, MD PhD, Anton Kulikovsky, Olga Senderova, Valentina Pepeliaeva, Sergey Meresiy, Alexander S. Luchinin, MD, Galina Milutina, Lubov Gavrilova, Ludmila Avdeeva, Dolgorzhap Dasheeva, Olga Vinogradova, MD PhD, Sergei M. Kulikov, PhD, Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5902.
https://doi.org/10.1182/blood-2019-131430
Published: 2019
Journal Articles

PF-114: A 4 th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1 T315I

Anna G. Turkina, Prof., MD, Olga Vinogradova, MD PhD, Elza Lomaia, MD PhD, Evgeniya Shatokhina, MD PhD, Oleg A. Shukhov, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Dzhariyat Shikhbabaeva, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, MD PhD, Nadia Siordia, MD, Vasily Shuvaev, MD, Jorge E. Cortes, MD, Robert Peter Gale, Michele Baccarani, MD, Oliver Ottmann, Prof, MD, Ilya Mikhailov, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1638.
https://doi.org/10.1182/blood-2019-127951
Published: 2019
Journal Articles

Phase-1 Study of PF-114 Mesylate in CML Failing Prior Tyrosine Kinase-Inhibitor Therapy

Anna G Turkina, Prof., MD, Olga Vinogradova, MD PhD, Elza Lomaia, MD, Evgeniya Shatokhina, MD PhD, Oleg Shukhov, MD PhD, Ekaterina Chelysheva, MD PhD, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, MD PhD, Nadia Siordia, MD, Dzhariyat Shikhbabaeva, Vasily Shuvaev, MD, Jorge E. Cortes, MD, Robert Peter Gale, Michele Baccarani, MD, Oliver G. Ottmann, MD, Ilya Mikhailov, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 790.
https://doi.org/10.1182/blood-2018-99-116803
Published: 2018
Journal Articles

Russian Experience of Bosutinib Use in Chronic Myeloid Leukemia Patients in Routine Clinical Practice

Vasily Shuvaev, MD, Olga Vinogradova, MD PhD, Irina Martynkevich, MD PhD, Novitskaya Natalya, MD, Mikhail Fominykh, MD, Svetlana Tsareva, Dzhariyat Shikhbabaeva, Maria Pankrashkina, Mikhail Chernikov, Nikolay Sharkunov, MD PhD, Irina Zotova, MD, Vera Udaleva, MD PhD, Ekaterina Motyko, MD, Sergei Voloshin, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5446.
https://doi.org/10.1182/blood-2018-99-114164
Published: 2018
Journal Articles

Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?

Tatiana Ionova, DSc, Natalia Bulieva, MD, Anatoly Golenkov, MDProf, Taras Gritsenko, MD, Lilia Kozlova, MD Prof, Galina Kuchma, MD PhD, Elza Lomaia, MD, Elena Machulaytene, MD, Tatiana Nikitina, PhD, Natalia Novitskaya, MD PhD, Elena Usacheva, MD PhD, Tatiana Shneider, MD, Elena Trifonova, MD PhD, Olga Vinogradova, MD PhD, Anna Zinkovskaya
Journal: Blood
Blood (2017) 130 (Supplement 1): 2181.
https://doi.org/10.1182/blood.V130.Suppl_1.2181.2181
Published: 2017
Journal Articles

Quality of Life (QoL) and Clinical Outcomes of Dasatinib Treatment in TKI-Naive and Early Switched from Imatinib Patients with Chronic Myeloid Leukemia in Chronic Phase (CP CML) in a Real World Setting

Tatyana Ionova, PhD, Natalia Bulieva, MD, Olga Vinogradova, MD PhD, Kira Kurbatova, Elza Lomaia, MD PhD, Tatyana Nikitina, MD PhD, Natalia Novitskaya, Anna Rodionova, MD PhD, Elena Usacheva, Marina Chukavina, Marina Shumkova
Journal: Blood
Blood (2016) 128 (22): 5456.
https://doi.org/10.1182/blood.V128.22.5456.5456
Published: 2016
Journal Articles

Clinical Significance of Additional Chromosomal Abnormalities In Ph-Positive and Ph-Negative Cells In Patients with Chronic Myeloid Leukemia Treated by Tyrosine Kinase Inhibitors

Anna G. Turkina, MD, PhD, Olga Vinogradova, PhD, Alexandra Vorontsova, PhD, Ekaterina Chelysheva, PhD, Olga Lazareva, PhD, Galina Gusarova, PhD, Elena Aseeva, PhD, Nina Khoroshko, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1683.
https://doi.org/10.1182/blood.V118.21.1683.1683
Published: 2011